Hyponatremia & Osmoregulation: SIADH vs Cerebral Salt Wasting

ABPN Neurocritical Care Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Neurologic Examination & Coma Assessment in the ICU

Current Examination, Blueprint & Preparation Neurologic Examination in Critically Ill Patients Coma Evaluation & Consciousness Alterations Delirium & Toxic-Metabolic Encephalopathy in the ICU

2 Chapter 2: Cerebral Physiology & Intracranial Dynamics

Cerebral Blood Flow, Metabolism & Autoregulation Intracranial Pressure & Compliance Cerebral Edema & Herniation Syndromes

3 Chapter 3: Intracranial Hypertension & Cerebral Perfusion Management

Tiered ICP Management Protocols Hyperosmolar Therapy & Fluid Management Advanced & Refractory ICP Interventions

4 Chapter 4: Airway, Mechanical Ventilation & Pulmonary ICU Management

Emergency Airway Management & Neuro-Intubation Mechanical Ventilation Strategies in Acute Brain Injury Tracheostomy & Ventilator Weaning in Neurocritical Care Pulmonary Complications in the Neuro-ICU Obstructive Lung Disease, Pulmonary Hypertension & Bronchoscopy

5 Chapter 5: Hemodynamics, Shock & Cardiovascular Management

Hemodynamic Monitoring & Blood Pressure Targets Vasoactive Agents: Inotropes, Vasopressors & Antihypertensives Cardiac Complications of Brain Injury

6 Chapter 6: Neuropharmacology, Analgesia & Sedation

ICU Sedation & Analgesia Neuromuscular Blockade & Monitoring Propofol Infusion Syndrome & Drug Toxicities Antiseizure Drug Pharmacology in the ICU

7 Bleeding, Thrombosis & Hematologic Emergencies

Warfarin & Heparin Reversal Direct Oral Anticoagulant (DOAC) Reversal Antiplatelet Management & Platelet Dysfunction Venous Thromboembolism Prophylaxis & Management Transfusion, Coagulopathy, TMA & Cellular-Therapy Neurotoxicity

8 Chapter 8: Systemic ICU Care, Fluids, Electrolytes & Endocrine

Hyponatremia & Osmoregulation: SIADH vs Cerebral Salt Wasting Diabetes Insipidus, Hypernatremia & Endocrine Crises Critical Care Prophylaxis, Nutrition & Infection Prevention

9 Systemic Trauma & Environmental Injury

Polytrauma, Chest Injury & Abdominal Hemorrhage Burns, Electrical Injury & Hanging

10 Cardiac Emergencies & Mechanical Support

IABP, Ventricular Devices & ECMO Acute Coronary, Valvular, Rhythm & Aortic Emergencies

11 Kidney Injury, Acid–Base & Renal Replacement

Acute Kidney Injury & Renal Drug Clearance Acid–Base Disorders, Electrolytes & Renal Replacement

12 Systemic Infection & Endocrine Emergencies

Sepsis, Endocarditis & Antimicrobial Principles Thyroid, Adrenal & Dysglycemic Emergencies

13 Gastrointestinal & Hepatic Emergencies

Acute Abdomen, GI Bleeding & Abdominal Compartment Syndrome Acute Liver Failure, Cirrhosis & Hepatic Drug Effects

14 Chapter 9: Neuroimaging in the Neuro-ICU

Non-Contrast CT & CT Angiography CT Perfusion & Advanced Perfusion Imaging Magnetic Resonance Imaging in Critical Illness

15 Chapter 10: Electrophysiology & Neuromonitoring

Continuous EEG & ACNS Standardized Critical Care Terminology Invasive Neuromonitoring: ICP & External Ventricular Drains Multimodal Monitoring: PbtO2, Microdialysis & Transcranial Doppler

16 Angiography, Electrodiagnosis & CSF Analysis

Conventional Angiography & Cranial–Spinal Shunts EMG, Nerve Conduction & Acute Muscle Disease CSF Analysis: Infection, Inflammation & Hemorrhage

17 Chapter 11: Bedside Procedures, Ultrasound & Death by Neurologic Criteria

Critical Care Procedural Skills Critical Care Ultrasound & Echocardiography Determination of Death by Neurologic Criteria

18 Chapter 12: Acute Ischemic Stroke & Reperfusion Therapies

Acute Ischemic Stroke Management & Thrombolysis Endovascular Thrombectomy & Large Vessel Occlusion Malignant Hemispheric & Cerebellar Infarction

19 Chapter 13: Spontaneous Intracerebral Hemorrhage & Intraventricular Hemorrhage

Acute Intraparenchymal Hemorrhage Management Intraventricular Hemorrhage & Hydrocephalus Surgical Evacuation & Minimally Invasive Surgery in ICH

20 Chapter 14: Aneurysmal Subarachnoid Hemorrhage & Delayed Cerebral Ischemia

Aneurysmal Subarachnoid Hemorrhage: Acute Resuscitation & Securing Delayed Cerebral Ischemia & Cerebral Vasospasm Non-Aneurysmal Subarachnoid Hemorrhage & Vascular Malformations

21 Venous, Spinal & Traumatic Vascular Disease

Cerebral Venous Thrombosis & Spinal Cord Infarction Traumatic Dissection, Carotid–Cavernous Fistula & Penetrating Injury

22 Chapter 15: Traumatic Brain & Spinal Cord Injury

Severe Traumatic Brain Injury & Contusions Acute Traumatic Spinal Cord Injury & Neurogenic Shock Spine Trauma, Fractures & Cord Syndromes

23 Chapter 16: Status Epilepticus, Seizures & Neuromuscular Emergencies

Status Epilepticus: Convulsive & Non-Convulsive Refractory & Super-Refractory Status Epilepticus Acute Neuromuscular Respiratory Failure

24 Chapter 17: Post-Cardiac Arrest Care, CNS Infections & Encephalitis

Targeted Temperature Management & Post-Cardiac Arrest Care Post-Cardiac Arrest Neuroprognostication Acute CNS Infections, Encephalitis & Inflammatory Emergencies

25 Neuroinflammation & Neurooncology

Fulminant Demyelination & Autoimmune Encephalitis Brain, Spinal & Leptomeningeal Cancer Emergencies

26 Pregnancy, Transplantation & Pediatric Care

Pregnancy, Postpartum & Post-Transplant Neurologic Care Pediatric Neurocritical Care

27 Chapter 18: Neurosurgical & Perioperative Emergencies

Postoperative Neurosurgical Complications Device Complications: EVDs, Shunts & ICP Monitors Cerebral Hyperperfusion Syndrome & Post-Interventional Emergencies

28 Chapter 19: Ethics, Palliative Care & Organ Donation in the Neuro-ICU

Communication, Surrogate Decision-Making & Conflict Resolution Neuroprognostication Ethics, Withdrawal of Life Support & Palliative Care Organ Donation & Management of the Deceased Donor

Hyponatremia & Osmoregulation: SIADH vs Cerebral Salt Wasting

Key Takeaways Explain This Topic AI

Distinguish hypotonic hyponatremia from glucose-related hypertonicity and laboratory pseudohyponatremia before assigning SIADH.

SIADH and salt wasting can both have concentrated urine and high urine sodium; the volume assessment and exclusion of adrenal deficiency are essential.

Severe hyponatremic symptoms warrant protocol-based 3% saline boluses with early reassessment; the initial goal is usually a 4–6 mEq/L rise, not immediate normalization.

In high-risk chronic hyponatremia, aim for 4–6 mEq/L per day and avoid exceeding 8 in any 24 hours; monitor for sudden water diuresis and overcorrection.

Last updated: October 2026

• Hyponatremia, SIADH, and Salt Wasting
• Confirm the Type of Sodium Disturbance

Sodium concentration reflects the balance of body water and exchangeable solute rather than sodium stores alone. Measure serum osmolality and glucose, assess medications and fluids, and establish the time course. Hyperglycemia can lower measured sodium through an extracellular water shift while increasing tonicity. Severe hyperlipidemia or hyperproteinemia can cause pseudohyponatremia with some laboratory methods. Neither situation should automatically receive the same treatment as symptomatic hypotonic hyponatremia.

AVP is synthesized in hypothalamic supraoptic and paraventricular nuclei, transported to the posterior pituitary, and released in response to osmotic and nonosmotic stimuli. Renal V2 signaling increases collecting-duct aquaporin-2 insertion and water retention. Hypovolemia, pain, nausea, stress, and drugs can sustain AVP even when plasma is hypotonic. Thus a concentrated urine is evidence of impaired water excretion, not proof of SIADH by itself.

Evaluate the examination, intake and output, weight trend, kidney function, urine osmolality and sodium, recent diuretics, and adrenal and thyroid context. Do not diagnose euvolemia from one CVP or IVC image. Ventilation, right-heart function, positioning, and measurement technique affect these findings. Adrenal deficiency can mimic SIADH and may be immediately dangerous; suspected adrenal crisis requires prompt treatment rather than waiting for a perfect diagnostic profile.

SIADH Versus Salt Wasting

SIADH typically combines hypotonic hyponatremia, inappropriately concentrated urine, and clinical euvolemia after exclusion of relevant renal, endocrine, drug, and volume causes. High urine sodium is common with adequate intake, but the concentration is affected by diuretics, intake, kidney disease, and prior treatment. Brain injury, pulmonary disease, infection, malignancy, and medications can contribute. Low uric acid and urea may support the pattern without establishing it alone.

Cerebral or renal salt wasting describes renal sodium loss with extracellular volume depletion in a relevant clinical setting. Definitions and differentiation from SIADH remain debated. Proposed mechanisms include altered sympathetic signaling and natriuretic factors, but a BNP measurement does not diagnose the syndrome. Look for sustained urinary salt loss, negative balance, polyuria, hemodynamic change, and response to carefully monitored replacement while excluding other causes of volume depletion.

Both syndromes may show elevated fractional urate excretion during hyponatremia. In proposed diagnostic approaches, FEurate tends to normalize after sodium correction in SIADH and remain elevated in renal salt wasting. This is the reverse of the erroneous claim that it stays elevated only in SIADH. Renal function, timing, medications, and the limitations of the approach matter; do not use it as an infallible standalone bedside test.

Treat the Patient and the Cause

A hypovolemic patient needs appropriate volume and sodium replacement. In aSAH, volume contraction can worsen perfusion and complicate DCI risk, so avoid reflexive water restriction when it would worsen depletion. Maintain euvolemia rather than prophylactic hypervolemia. Selected mineralocorticoid treatment can reduce natriuresis, but monitor potassium, fluid balance, edema, and pressure. A sodium value alone does not mandate fludrocortisone for every patient.

For a genuinely euvolemic SIADH presentation without severe symptoms, treatment may include water-intake management, removal of causes, and selected solute or other therapies. The neurologic disease and perfusion needs affect the choice. There is no universal rule that fluid restriction is forbidden in every TBI patient. Vaptans can cause rapid aquaresis and overcorrection and are not emergency substitutes for hypertonic saline in a seizing patient. Kidney and liver function, interactions, and local expertise influence use.

Severe Symptoms: Raise Sodium Promptly but Deliberately

Seizure, severe encephalopathy, respiratory compromise, or herniation attributable to hypotonic hyponatremia requires urgent monitored treatment. Give a protocol-based 3% saline bolus, commonly 100 mL over ten minutes or 150 mL over twenty minutes depending on the selected guideline, with repeat assessment and additional boluses if needed. Do not combine two protocols into an automatic unmonitored series. Treat the airway and seizures in parallel.

The early goal is generally a sodium increase of approximately 4–6 mEq/L with clinical improvement, not immediate correction to normal or high-normal sodium. One bolus does not guarantee that rise, and no fixed 50% reduction in brain water can be promised. Recheck sodium frequently, follow urine output, account for all fluids and potassium replacement, and change the plan as symptoms and measurements evolve. Once immediate danger improves, slow correction according to duration and osmotic demyelination risk.

Prevent and Rescue Overcorrection

Chronic adaptation reduces brain osmoles, making rapid sodium elevation dangerous. Important ODS risks include very low starting sodium, alcohol use disorder, malnutrition, hypokalemia, and advanced liver disease. In high-risk patients, target 4–6 mEq/L per day and avoid a rise above 8 in any 24-hour period. Other guideline limits vary, and a conservative plan can be selected when duration or risk is uncertain. These are cumulative limits across treatment transitions, not a fresh allowance at midnight.

A sudden water diuresis can accelerate correction after volume or cortisol replacement even when hypertonic saline has stopped. If sodium is rising excessively, stop the driver, obtain urgent expert input, and consider protocol-based desmopressin and electrolyte-free water to halt aquaresis and relower safely. Dose and fluid rate depend on the measured trajectory and monitoring; an identical high-rate D5W infusion is not appropriate for every patient.

ODS can appear days after initial improvement with dysarthria, dysphagia, movement abnormalities, weakness, or altered consciousness. MRI findings may lag, and not every case has the same pontine pattern. Prevention and careful response to overcorrection are central. Document the starting sodium, elapsed intervals, risk factors, total rise, and rescue plan at each handoff.

Source: 2024 expert review of hyponatremia treatment safeguards and 2023 aSAH guideline summary .

Decision Review

• Presentation Immediate reasoning
• Severe symptoms Monitored hypertonic treatment and airway/seizure support
• Volume depletion Replace losses and protect perfusion
• High ODS risk Conservative cumulative correction and frequent monitoring